Main Content

A REVOLUTION IN TREATING AUTOINFLAMMATORY & ORPHAN DISEASES
COVID-19 VIEW PRESS RELEASES COVID-19 VIEW PRESS RELEASES VIEW PRESENTATIONS VIEW PRESENTATIONS

We develop life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.